Suppr超能文献

“一度房室传导阻滞——一种良性病症?”对一度房室传导阻滞患者使用植入式心脏监测器可发现是否存在或进展为更高级别的阻滞或需要植入起搏器的心动过缓。

"First-degree AV block-a benign entity?" Insertable cardiac monitor in patients with 1st-degree AV block reveals presence or progression to higher grade block or bradycardia requiring pacemaker implant.

作者信息

Lewalter Thorsten, Pürerfellner Helmut, Ungar Andrea, Rieger Guido, Mangoni Lorenza, Duru Firat

机构信息

Peter Osypka Heart Center Munich, Hospital Munich-Thalkirchen, Am Isarkanal, 36 81379, Munich, Germany.

Department of Cardiology, Krankenhaus der Elisabethinen-Academic Teaching Hospital, Linz, Austria.

出版信息

J Interv Card Electrophysiol. 2018 Aug;52(3):303-306. doi: 10.1007/s10840-018-0439-7. Epub 2018 Aug 13.

Abstract

BACKGROUND

First-degree AV block has in the past generally been considered a benign condition. A few recent studies have shown that 1st-degree AV block is associated with an increased risk for heart failure, pacemaker (IPG) implantation, and death. We investigated the outcomes of patients who received an insertable cardiac monitor (ICM) (Medtronic Reveal XT®) within the scope of the INSIGHT XT study and had 1st-degree AV block at baseline.

METHODS

The observational, international, multi-center INSIGHT (R)XT study prospectively enrolled 1003 patients implanted with an ICM for arrhythmia diagnosis, irrespective of the clinical indication. This analysis includes 37 patients who had documented 1st-degree AV block at enrolment. Patients with known concurrent higher grade block at enrolment were excluded.

RESULTS

The indications for rhythm monitoring and ICM implantation were syncope/pre-syncope in 54.1%, cryptogenic stroke in 18.9%, AF with rhythm control intervention in 21.6%, and unexplained palpitations in 5.4%. Mean age was 68 ± 14 years, 75.7% were male, and concurrent bundle branch block was present in 8.1%. The median follow-up time was 12.2 months (IQR3.9-15.9). Fifteen patients (40.5%) received an IPG during the follow-up, and in 93.3% of the cases, the implant was needed to treat a now detected more severe bradycardia or progression of the conduction disease.

CONCLUSIONS

ICM either revealed progression of 1st-degree AV block to a higher grade block (53%) or detected an already existing more severe bradycardia warranting an IPG in 40.5% patients. This finding supports the conclusion that 1st-degree AV block might be a risk marker for more severe intermittent conduction disease and is not benign in all patients. Further studies may reveal patient subgroups which are at risk for demonstrating or developing higher grade AV block and may warrant a future IPG implantation.

摘要

背景

一度房室传导阻滞在过去通常被认为是一种良性疾病。最近的一些研究表明,一度房室传导阻滞与心力衰竭、植入起搏器(IPG)及死亡风险增加有关。我们在INSIGHT XT研究范围内调查了接受植入式心脏监测器(ICM)(美敦力Reveal XT®)且基线时存在一度房室传导阻滞的患者的结局。

方法

观察性、国际性、多中心INSIGHT(R)XT研究前瞻性纳入了1003例植入ICM用于心律失常诊断的患者,不考虑临床适应证。该分析包括37例入组时记录有一度房室传导阻滞的患者。入组时已知合并更高程度房室传导阻滞的患者被排除。

结果

进行心律监测及植入ICM的适应证为晕厥/先兆晕厥占54.1%,隐源性卒中占18.9%,房颤且进行节律控制干预占21.6%,不明原因心悸占5.4%。平均年龄为68±14岁,75.7%为男性,8.1%合并束支传导阻滞。中位随访时间为12.2个月(四分位间距3.9 - 15.9)。15例患者(40.5%)在随访期间接受了IPG植入,在93.3%的病例中,植入是为了治疗新发现的更严重心动过缓或传导疾病进展。

结论

ICM要么显示一度房室传导阻滞进展为更高程度的阻滞(53%),要么在40.5%的患者中检测到已存在的更严重心动过缓,需要植入IPG。这一发现支持以下结论:一度房室传导阻滞可能是更严重间歇性传导疾病的风险标志物,并非在所有患者中都是良性的。进一步的研究可能会揭示有发生或发展为更高程度房室传导阻滞风险的患者亚组,可能需要未来植入IPG。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验